FundedIQ
Biotechnology

Medexus Pharma: Funding, Investors & Team (Oct 2026)

Medexus Pharma is a pharmaceutical company specializing in rare disease medications. They offer a diverse range of healthcare products targeting various conditions such as rheumatology, autoimmune diseases, pediatrics, and specialty oncology. These products are made available to healthcare professionals and patients alike.

www.medacpharma.com LinkedIn Chicago, United States 101-250 employees
Biotechnology Medical Device Pharmaceutical
Total raised
$7.3M
Rounds
1
Latest
Undisclosed round
Sep 2023

Medexus Pharma has raised $7.3M across 1 funding round on record, the most recent an undisclosed round of $7.3M announced in Sep 2023.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Medexus Pharma Company Profile and Key Stats

Total funding raised
$7.3M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$7.3M in Sep 2023
Employees
101-250
reported band
Headquarters
Chicago, United States

Latest funding round on record: Sep 2023.

Medexus Pharma Funding Rounds

Date
Round
Amount
Undisclosed round
$7.3M

Medexus Pharma Founders and Leadership Team

Name
Role
Contact
Ken D'entremont
CEO
—

No contact details are on record for this team yet.

Medexus Pharma Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Medexus Pharma's latest round of $7.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Medexus Pharma in Biotechnology and Chicago

Companies Similar to Medexus Pharma

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Medexus Pharma Funding FAQs

What does Medexus Pharma do?

Medexus Pharma is a pharmaceutical company specializing in rare disease medications. They offer a diverse range of healthcare products targeting various conditions such as rheumatology, autoimmune diseases, pediatrics, and specialty oncology. These products are made available to healthcare professionals and patients alike.

How much funding has Medexus Pharma raised?

Medexus Pharma has raised $7.3M across 1 round on record. The most recent is an undisclosed round of $7.3M announced in Sep 2023.

When did Medexus Pharma last raise funding?

Medexus Pharma's most recent funding round on record is an undisclosed round of $7.3M, announced in Sep 2023.

Who is the CEO of Medexus Pharma?

Ken D'entremont is listed as CEO at Medexus Pharma.

Where is Medexus Pharma headquartered?

Medexus Pharma is based in Chicago, Illinois, United States.

How many employees does Medexus Pharma have?

Medexus Pharma is in the 101-250 employee band.

How does Medexus Pharma's funding compare to other Biotechnology startups?

Medexus Pharma's latest round of $7.3M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Medexus Pharma Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Medexus Pharma is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.